Success Metrics

Clinical Success Rate
92.3%

Based on 12 completed trials

Completion Rate
92%(12/13)
Active Trials
1(4%)
Results Posted
17%(2 trials)
Terminated
1(4%)

Phase Distribution

Ph phase_1
2
8%
Ph phase_3
1
4%
Ph phase_4
1
4%
Ph not_applicable
15
63%
Ph phase_2
2
8%

Phase Distribution

2

Early Stage

2

Mid Stage

2

Late Stage

Phase Distribution21 total trials
Phase 1Safety & dosage
2(9.5%)
Phase 2Efficacy & side effects
2(9.5%)
Phase 3Large-scale testing
1(4.8%)
Phase 4Post-market surveillance
1(4.8%)
N/ANon-phased studies
15(71.4%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

85.7%

12 of 14 finished

Non-Completion Rate

14.3%

2 ended early

Currently Active

1

trials recruiting

Total Trials

24

all time

Status Distribution
Active(6)
Completed(12)
Terminated(2)
Other(4)

Detailed Status

Completed12
Not yet recruiting4
unknown4
Withdrawn1
Enrolling by invitation1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
24
Active
1
Success Rate
92.3%
Most Advanced
Phase 4

Trials by Phase

Phase 12 (9.5%)
Phase 22 (9.5%)
Phase 31 (4.8%)
Phase 41 (4.8%)
N/A15 (71.4%)

Trials by Status

completed1250%
withdrawn14%
enrolling_by_invitation14%
not_yet_recruiting417%
terminated14%
unknown417%
active_not_recruiting14%

Recent Activity

Clinical Trials (24)

Showing 20 of 24 trialsScroll for more
NCT07195708Not Applicable

Orbera365 Intragastric Balloon System (Abbreviated as'Orbera365')

Not Yet Recruiting
NCT07491822Not Applicable

A Single-Arm, Single-Center, Phase II Clinical Study of Camrelizumab Combined With Radiochemotherapy as Neoadjuvant Therapy for Early-Stage Triple-Negative Breast Cancer

Not Yet Recruiting
NCT04597008Phase 3

Topical Antibiotic Therapy to Reduce Infection After Operative Treatment of Fractures at High Risk of Infection: TOBRA

Completed
NCT05461495Not Applicable

NYUCI-ES: Psychosocial Intervention to Improve Health Outcomes for Chinese and Korean ADRD Caregivers

Active Not Recruiting
NCT06911437

Clinical Study on the Combination of Xiaoyu Zhitong Formula and Lymphatic Drainage Technique to Improve the Symptoms of Knee Pain and Swelling in Cold Dampness Obstruction Type

Enrolling By Invitation
NCT06858969Phase 2

Chidamide in Combination With PD-1 Inhibitor, Bevacizumab, and XELOX for Metastatic Colorectal Cancer

Not Yet Recruiting
NCT06536985Not Applicable

Effect of an Oral Frailty Measures Intervention Programs in Institutionalized Elders

Not Yet Recruiting
NCT05697679Not Applicable

Effects of Physical Activiy Promotion Intervention Programs in Emerging Adulthood

Completed
NCT06191523Not Applicable

The Effect of Melatonin as an Adjuvant Therapy for Preterm Neonates With Sepsis

Completed
NCT05863260

Tislelizumab Combing Chemoradiotherapy in Recurrent Cervical Cancer

Unknown
NCT05521282Phase 4

The Efficacy of Qianglidingxuan Tablets in the Treatment of Hypertension

Completed
NCT05402306Not Applicable

The Feasibility and Efficacy of a Two-week MCT Treatment of Anxiety Disorders in a Group Setting

Unknown
NCT04667936

Evaluation of Sedation in COVID-19 ARDS

Completed
NCT02452398Not Applicable

Clinical Evaluation of Hair Removal and Permanent Hair Reduction for Skin Types VI Using Intense Pulsed Light

Terminated
NCT02892357Phase 1

Efficacy of Traditional Chinese Medicine Combined With Omeprazole in Patients With Non-erosive Reflux Disease

Unknown
NCT03213574Not Applicable

Impact of GDT in Robot-assisted Laparoscopic Urological Surgery for Low to Moderate Risk Patients

Withdrawn
NCT01380834Not Applicable

Bilateral Paravertebral Blockade (T7-10) vs. Incisional Local Anesthetic Administration for Pediatric Patients

Completed
NCT03321942Not Applicable

Treatment of Chronic Renal Failure With Adipose Tissue-derived Mesenchymal Stem Cells

Unknown
NCT02765360Not Applicable

EIT Study With COPD and OHS Patients (EIT Step 2)

Completed
NCT00474461Phase 1

Cardiac Stem Cell Infusion in Patients With Ischemic CardiOmyopathy (SCIPIO)

Completed

Drug Details

Intervention Type
DEVICE
Total Trials
24